Delivery Order SPE2DB20D2014-SPE2DB25FD18B
Award Date 9/29/25
Potential Completion Date 9/30/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $13,593.94 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication primarily used to treat moderate-to-severe...
- The Defense Logistics Agency awarded a $31,152.11 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes with a completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a contract value of $42,767.05. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,010.37 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Dupixent 300 mg/2 ml syringes with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory...
- The Defense Logistics Agency awarded a delivery order valued at $10,256.76 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on September 19, 2025, with an ultimate completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a prescription biologic medication used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $19,052.49 on September 3, 2025, for the supply of Dupixent 200 mg/1.14 ml syringes. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. The contract is scheduled for ultimate completion by September 4, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. Dupixent is...
- The Defense Logistics Agency awarded a $10,256.76 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions, and this award reflects the Department of Defense's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a $5,128.38 delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Dupixent 200 mg/1.14 ml syringes. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of April 25, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Dupixent 300 mg/2 ml syringes with a ceiling value of $35,737.05. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for ultimate completion by July 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent is a biologic treatment used for various inflammatory and...
- The Defense Logistics Agency awarded a $79,236.52 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL syringes on September 4, 2025, with completion targeted for September 5, 2025. This competitive, firm fixed-price award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication used to treat various inflammatory conditions, including asthma, atopic...